BARCLAYS PLC

Position in IMNM — Immunome Inc.

CIK 312069 LONDON, X0

Position in IMNM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$558,377

+$36,691 QoQ

Shares Held

26,351

+10.5% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#111

of 200 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. IMNM ranks #151 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$558,377	26,351	+10.5%	Shares	Defined	2026-08-14
2026-03-31	$521,686	23,854	-90.3%	Shares	Defined	2026-05-15
2025-12-31	$5,285,476	246,065	+18.0%	Shares	Sole	2026-02-13
2025-09-30	$2,441,687	208,513	-9.3%	Shares	Sole	2026-03-31
2025-06-30	$2,137,818	229,873	+81.6%	Shares	Sole	2026-02-27
2025-03-31	$851,875	126,579	+21.3%	Shares	Sole	2026-03-17
2024-12-31	$1,107,814	104,314	-1.5%	Shares	Sole	2026-03-19
2024-09-30	$1,548,053	105,886	+125.9%	Shares	Sole	2026-03-31
2024-06-30	$567,127	46,870	+61.7%	Shares	Sole	2026-03-23
2024-03-31	$715,571	28,994	-64.8%	Shares	Sole	2026-03-24
2023-12-31	$882,268	82,455	—	Shares	Sole	2026-03-24
No filing history on record for this holder in this stock.